Serologic and Clinical Response to Treatment of Systemic Vasculitis and Associated Autoimmune Disease with Intravenous Immunoglobulin

Publisher： Karger

E-ISSN： 1423-0097|119|3|231-238

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.119, Iss.3, 2011-06, pp. : 231-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of intravenous immunoglobulin in the treatment of Kawasaki disease

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 21, Iss. 1, 2018-01 ,pp. : 64-69

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neutrophil‐Related Gene Expression and Low‐Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 7, 2015-07 ,pp. : 1922-1932

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunoglobulin G Values before Treatment Are Correlated With the Responsiveness to Initial Intravenous Immunoglobulin Therapy for Kawasaki Disease

By  

International Archives of Allergy and Immunology, Vol. 164, Iss. 2, 2014-06 ,pp. : 83-88

Karger

Access to resources Recommend Favorite

Influence of Intravenous Immunoglobulin Treatment on Thrombopoiesis

By  

Transfusion Medicine and Hemotherapy, Vol. 39, Iss. 3, 2012-05 ,pp. : 217-220

Karger

Access to resources Recommend Favorite

Prolonged Treatment with Low-Dose Intravenous Pulse Cyclophosphamide May Reduce Rate of Relapse in ANCA-Associated Vasculitis

By  

Nephron Clin Pract, Vol. 97, Iss. 4, 2004-11 ,pp. : c154-c159

Karger

Access to resources Recommend Favorite